Toll Brothers
TOL
Meritage Homes
MTH
Taylor Morrison Home
TMHC
D.R. Horton
DHI
KB Home
KBH
US Stock MarketDetailed Quotes
EDIT Editas Medicine
- 1.340
- -0.110-7.59%
Close Jan 8 16:00 ET
- 1.350
- +0.010+0.75%
Post 20:01 ET
110.61MMarket Cap-0.53P/E (TTM)
1.480High1.330Low1.92MVolume1.470Open1.450Pre Close2.64MTurnover2.49%Turnover RatioLossP/E (Static)82.55MShares11.58052wk High0.63P/B103.61MFloat Cap1.16052wk Low--Dividend TTM77.32MShs Float99.950Historical High--Div YieldTTM10.35%Amplitude1.160Historical Low1.373Avg Price1Lot Size
Editas Medicine News
Editas Medicine to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Why Is Editas Medicine, Inc. (EDIT) Among the Top CRISPR Stocks to Invest In?
Clear Street Initiates Editas Medicine(EDIT.US) With Buy Rating, Announces Target Price $4
Evercore Maintains Editas Medicine(EDIT.US) With Buy Rating, Cuts Target Price to $5
Evercore ISI Group Maintains Outperform on Editas Medicine, Lowers Price Target to $5
J.P. Morgan Downgrades Editas Medicine(EDIT.US) to Sell Rating
Analysts Offer Insights on Healthcare Companies: Affimed (AFMD), Editas Medicine (EDIT) and Trevi Therapeutics (TRVI)
Express News | Editas Medicine Inc : JP Morgan Cuts to Underweight From Neutral
Morgan Stanley Maintains Editas Medicine(EDIT.US) With Hold Rating
A Quick Look at Today's Ratings for Editas Medicine(EDIT.US), With a Forecast Between $3 to $3
Editas Medicine Price Target Lowered to $8 From $10 at Baird
Editas Medicine Reshapes Future With In Vivo Focus Amid Major Workforce Cuts
Editas Medicine Is Maintained at Sector Perform by RBC Capital
Editas Medicine Maintains Hold Rating Amid Strategic Shifts and Financial Challenges
Walmart To Rally Over 22%? Here Are 10 Top Analyst Forecasts For Friday
This Toll Brothers Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Editas Medicine Shares Are Trading Lower After Stifel and Chardan Capital Downgraded the Stock and Multiple Firms Cut Their Respective Price Targets.
Barclays Maintains Equal-Weight on Editas Medicine, Lowers Price Target to $3
4 Stocks to Watch on Friday: EVGO, ELF and More
A Quick Look at Today's Ratings for Editas Medicine(EDIT.US), With a Forecast Between $3 to $8
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
